Literature DB >> 17074848

Staphylococcal enterotoxin B in vivo modulates both gamma interferon receptor expression and ligand-induced activation of signal transducer and activator of transcription 1 in T cells.

R Plaza1, J L Rodriguez-Sanchez, C Juarez.   

Abstract

Superantigens (SAg) are bacterial exotoxins that provoke extreme responses in the immune system; for example, the acute hyperactivation of SAg-reactive T cells that leads to toxic shock syndrome is followed within days by strong immunosuppression. The gamma interferon (IFN-gamma) response is deeply affected in both extremes. The implication of IFN-gamma in the pathophysiology of lethal shock induced in mice after a secondary challenge with the SAg staphylococcal enterotoxin B (SEB) prompted us to study the regulation of IFN-gamma secretion and the intracellular response. We demonstrate in this study that a rechallenge with SEB becomes lethal only when given inside a critical time window after SEB priming and is associated with an increase of IFN-gamma serum release 72 h after priming. However, at this time, a selective blockade of IFN-gamma/STAT1 signaling develops in spleen cells, correlating with a lack of expression of the IFN-gamma receptor beta subunit and STAT1 in the T-cell population. Selective blockade of the STAT1 signaling pathway--while simultaneously maintaining STAT3 signaling and expression--may be a protective mechanism that shortens IFN-gamma production during the Th1 effector response. This blockade may also have consequences on switching towards a suppressor phenotype with chronic exposure to the superantigen.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17074848      PMCID: PMC1828398          DOI: 10.1128/IAI.01220-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

1.  Implication of STAT1 and STAT3 transcription factors in the response to superantigens.

Authors:  R Plaza; S Vidal; J L Rodriguez-Sanchez; C Juarez
Journal:  Cytokine       Date:  2004-01-07       Impact factor: 3.861

2.  Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.

Authors:  Gila Arad; Dalia Hillman; Revital Levy; Raymond Kaempfer
Journal:  Immunol Lett       Date:  2004-02-15       Impact factor: 3.685

3.  A high-efficiency HeLa cell nuclear transcription extract.

Authors:  D J Shapiro; P A Sharp; W W Wahli; M J Keller
Journal:  DNA       Date:  1988 Jan-Feb

Review 4.  Roles of STAT3 defined by tissue-specific gene targeting.

Authors:  S Akira
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

5.  Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses.

Authors:  Yaozhong Ding; Dongmei Chen; Adel Tarcsafalvi; Ruthie Su; Lihui Qin; Jonathan S Bromberg
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

6.  Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.

Authors:  Per Anderson; Anette Sundstedt; Li Li; Emma J O'Neill; Suling Li; David C Wraith; Ping Wang
Journal:  Int Immunol       Date:  2003-11       Impact factor: 4.823

7.  CD4+CD25+ and CD4+CD25- T cells act respectively as inducer and effector T suppressor cells in superantigen-induced tolerance.

Authors:  Pascal Feunou; Lionel Poulin; Claude Habran; Alain Le Moine; Michel Goldman; Michel Y Braun
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

8.  Stat1 implication in the immune response to superantigens in vivo.

Authors:  R Gimeno; J Codony-Servat; M Plana; J L Rodriguez-Sanchez; C Juarez
Journal:  J Immunol       Date:  1996-02-15       Impact factor: 5.422

9.  V beta-specific stimulation of human T cells by staphylococcal toxins.

Authors:  J Kappler; B Kotzin; L Herron; E W Gelfand; R D Bigler; A Boylston; S Carrel; D N Posnett; Y Choi; P Marrack
Journal:  Science       Date:  1989-05-19       Impact factor: 47.728

10.  Interferon gamma signaling alters the function of T helper type 1 cells.

Authors:  G Z Tau; T von der Weid; B Lu; S Cowan; M Kvatyuk; A Pernis; G Cattoretti; N S Braunstein; R L Coffman; P B Rothman
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  6 in total

1.  Relationship of varying patterns of cytokine production to the anorexic and neuroendocrine effects of repeated Staphylococcal enterotoxin A exposure.

Authors:  Daniella Urbach-Ross; Beth Crowell; Alexander W Kusnecov
Journal:  J Neuroimmunol       Date:  2008-04-14       Impact factor: 3.478

2.  Staphylococcal enterotoxin B-induced microRNA-155 targets SOCS1 to promote acute inflammatory lung injury.

Authors:  Roshni Rao; Sadiye Amcaoglu Rieder; Prakash Nagarkatti; Mitzi Nagarkatti
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

3.  MHC Class II Activation and Interferon-γ Mediate the Inhibition of Neutrophils and Eosinophils by Staphylococcal Enterotoxin Type A (SEA).

Authors:  Ana P Ferreira-Duarte; Anelize S Pinheiro-Torres; Gabriel F Anhê; Antônio Condino-Neto; Edson Antunes; Ivani A DeSouza
Journal:  Front Cell Infect Microbiol       Date:  2017-12-13       Impact factor: 5.293

Review 4.  Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens.

Authors:  Stephen W Tuffs; S M Mansour Haeryfar; John K McCormick
Journal:  Pathogens       Date:  2018-05-29

5.  Activation of STAT6 by intranasal allergens correlated with the development of eosinophilic chronic rhinosinusitis in a mouse model.

Authors:  Hongqi Wei; Longjiang Xu; Peng Sun; Hongyu Xing; Zhengwen Zhu; Jisheng Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

6.  Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality.

Authors:  Gabriela A Ferreyra; Jason M Elinoff; Cumhur Y Demirkale; Matthew F Starost; Marilyn Buckley; Peter J Munson; Teresa Krakauer; Robert L Danner
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.